Latest Funds From Operations News

Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.

Bellevue Gold Limited surged to record underlying free cash flow of A$158 million in the March 2026 quarter, driven by a 28% jump in ore grades and increased production. The company also advanced exploration with a new high-grade discovery and progressed its $35-40 million paste plant project while maintaining a strong sustainability profile.

Minerals 260 has locked in a $220 million funding deal with Franco-Nevada, combining royalty and equity financing to fast-track its 4.5Moz Bullabulling Gold Project. Strong drilling results and accelerated project work underpin a development timeline targeting first production by end 2028.

Carnavale Resources has secured a key mining lease and reported robust high-grade gold drilling results at Kookynie, keeping its Bankable Feasibility Study on track for early Q3 2026 delivery.

KGL Resources delivers a robust Baseline Economic Model for its Jervois Copper-Silver-Gold Project, highlighting a pre-tax NPV8 of A$1.226 billion and a 37% IRR, underpinning imminent project financing and construction plans.

Yancoal Australia posted a record 38.6 million tonnes of attributable saleable coal in 2025, up 5% on 2024, but net profit after tax plunged 64% to A$440 million amid softer coal prices. The miner maintained disciplined cost control and declared A$769 million in fully franked dividends.

N1 Holdings delivered record settlement volumes and a 127% surge in quarterly cash receipts despite challenging market conditions, driven by disciplined funding and operational efficiency.

Black Cat Syndicate posted solid operating cash flow of A$61 million in the March quarter, driven by the ramp-up at Kal East and a strategic $20 million expansion of the Lakewood processing facility. The company also reported a 95% increase in antimony resources at Mt Clement, signaling growth potential beyond gold.

Hastings Technology Metals is on track to commission its Kabin Buri Hydromet Plant in Thailand by June 2026, aiming for first production of premium Mixed Rare Earth Chloride flakes by Q4. The plant promises near-term revenue streams and leverages lower operating costs in Thailand's Eastern Economic Corridor.

Scentre Group’s first-quarter update reveals robust sales and visitation gains, near-full occupancy, and steady capital management moves, underpinning its confidence in 2026 earnings growth despite geopolitical uncertainties.

Scentre Group's first quarter update reveals robust retail sales growth and strong leasing metrics, alongside significant capital management moves including bond redemption and a major joint venture stake sale.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.